Classification
- Anatomical main groupAAlimentary tract and metabolism
- Therapeutic subgroupA11
- Pharmacological subgroupA11C
- Chemical subgroupA11CCVitamin d and analogues
- Chemical substanceA11CC01Ergocalciferol
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 79 registrations
- D-Forte50000 UNIT · Capsule · Euro-Pharm International Canada INC
- Sandoz D-Forte50000 UNIT · Capsule · Sandoz Canada Incorporated
- Osto-D250000 UNIT · Capsule · Paladin Pharma INC.
- Radiostol Cap 50000IU50000 UNIT / CAP · Capsule · Allen & Hanburys A Glaxo Canada LTD. Co.
Brazil
Anvisa · 50 registrations
At a glance
- ATC code
- A11CC01
- ATC group
- Alimentary tract and metabolism
- Registers
- 8
- Historical lists
- 1
- Registrations
- 160
- With their own page
- 25
- Companies
- 107
All medicines with Ergocalciferol
Human medicines from every register that match Ergocalciferol by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
153 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Ergocalciferol | United States | 50,000 IU | capsule | Marketed | Sigmapharm Labs LLC |
| Drisdol | United States | 50,000 IU | capsule | Marketed | Esjay Pharma |
| Vitamin D | United States | 50,000 IU | capsule | Marketed | Chase Chem |
| Deltalin | United States | 50,000 IU | capsule | Not marketed | Lilly |
| Vitalipid AdultosCombination | Spain | 0,5 µg + 15 µg + 0,91 mg + 194,1 µg | concentrado para solución para perfusión | Marketed | Fresenius Kabi España, S.A.U. |
| Vitalipid InfantilCombination | Spain | 1 µg + 20 µg + 0,64 mg + 135,3 µg | concentrado para solución para perfusión | Marketed | Fresenius Kabi España, S.A.U. |
| Vitintra Adult, infusievloeistof (concentraat)Combination | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Fresenius Kabi Nederland B.V. | |
| Vitintra Infant, infusievloeistof (concentraat)Combination | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Fresenius Kabi Nederland B.V. | |
| GerovitalCombination | Brazil | Authorised | Ems S/A | ||
| Vitalipid N AdultCombination | Serbia | 0.91mg/mL+194.1mcg/mL+15mcg/mL+0.5mcg/mL | koncentrat za emulziju za infuziju | Authorised | Fresenius Kabi D.O.O. Beograd |
| Vitalipid N Adult InjectionCombination | Singapore | 330 iu/ml + 20 iu/ml + 1 iu/ml + 15 mcg/ml | injection | Authorised | Fresenius Kabi (Singapore) Pte LTD |
| Vitalipid N InfantCombination | Serbia | 0.64mg/mL+135.3mcg/mL+20mcg/mL+1mcg/mL | koncentrat za emulziju za infuziju | Authorised | Fresenius Kabi D.O.O. Beograd |
| Vitalipid N Infant InjectionCombination | Singapore | 230 iu/ml + 40 iu/ml + 0.7 iu/ml + 20 mcg/ml | injection | Authorised | Fresenius Kabi (Singapore) Pte LTD |
| Vitamin ADCombination | Serbia | 22522i.j./mL+5000i.j./mL | oralne kapi, rastvor | Authorised | Hemofarm Ad VRŠAc |
| Berocca PNCombination | United States | 50MG/ML; 0.03MG/ML; 0.0025MG/ML; 7.5MG/ML; 100 IU/ML; 0.2MG/ML; 20MG/ML; 2MG/ML; 5'-PHOSPHATE SODIUM 1.8MG/ML; 1.5MG/ML; 1,650 IU/ML; 5 IU/ML | injectable | Not marketed | Roche |
| M.V.C. 9+3Combination | United States | 10MG/ML; 0.006MG/ML; 0.5MCG/ML; 1.5MG/ML; 20 IU/ML; 0.04MG/ML; 4MG/ML; 0.4MG/ML; 5'-PHOSPHATE SODIUM 0.36MG/ML; 0.3MG/ML; 330 UNITS/ML; 1 IU/ML | injectable | Not marketed | Abraxis Pharm |
| M.V.I.-12 AdultCombination | United States | 10MG/ML; 0.006MG/ML; 0.5MCG/ML; 1.5MG/ML; 20 IU/ML; 0.04MG/ML; 4MG/ML; 0.4MG/ML; 5'-PHOSPHATE SODIUM 0.36MG/ML; 0.3MG/ML; 330 UNITS/ML; 1 IU/ML, 20MG/ML; 0.006MG/ML; 0.05MCG/ML; 1.5MG/ML; 0.0005MG/ML; 0.06MG/ML; 4MG/ML; 0.6MG/ML; 5'-PHOSPHATE SODIUM 0.36MG/ML; 0.6MG/ML; 0.1MG/ML; 1MG/ML, 20MG/ML; 0.006MG/ML; 0.5MCG/ML; 1.5MG/ML; 20 IU/ML; 0.6MG/ML; 4MG/ML; 0.4MG/ML; 0.36MG/ML; 0.6MG/ML; 330 UNIT | injectable | Not marketed | Hospira |
| M.V.I.-12 LyophilizedCombination | United States | 100MG/VIAL; 0.06MG/VIAL; 0.005MG/VIAL; 15MG/VIAL; 5MCG/VIAL; 0.4MG/VIAL; 40MG/VIAL; 4MG/VIAL; 5'-PHOSPHATE SODIUM 3.6MG/VIAL; 3MG/VIAL; 1MG/VIAL; 10MG/VIAL | injectable | Not marketed | Teligent |
| M.V.I. AdultCombination | United States | 200MG/VIAL; 0.06MG/VIAL; 0.005MG/VIAL; 15MG/VIAL; 0.005MG/VIAL; 0.6MG/VIAL; 40MG/VIAL; 6MG/VIAL; 5'-PHOSPHATE SODIUM 3.6MG/VIAL; 6MG/VIAL; 1MG/VIAL; 10MG/VIAL; 0.15MG/VIAL | injectable | Not marketed | Hospira |
| M.V.I. Adult (Pharmacy Bulk Package)Combination | United States | 200MG/5ML; 0.06MG/5ML; 0.005MG/5ML; 15MG/5ML; 0.005MG/5ML; 0.6MG/5ML; 40MG/5ML; 6MG/5ML; 5'-PHOSPHATE SODIUM 3.6MG/5ML; 6MG/5ML; 1MG/5ML; 10MG/5ML; 0.15MG/5ML | injectable | Not marketed | Hospira |
| M.V.I. PediatricCombination | United States | 80MG/VIAL; 0.02MG/VIAL; 0.001MG/VIAL; 5MG/VIAL; 0.01MG/VIAL; 0.14MG/VIAL; 17MG/VIAL; 0.2MG/VIAL; 1MG/VIAL; 5'-PHOSPHATE SODIUM 1.4MG/VIAL; 1.2MG BASE/VIAL; 0.7MG/VIAL; 7MG/VIAL | for solution | Not marketed | Hospira |
| MVC PlusCombination | United States | 10MG/ML; 0.006MG/ML; 0.5MCG/ML; 1.5MG/ML; 20 IU/ML; 0.04MG/ML; 4MG/ML; 0.4MG/ML; 5'-PHOSPHATE SODIUM 0.36MG/ML; 0.3MG/ML; 330 UNITS/ML; 1 IU/ML | injectable | Not marketed | Watson Labs |
| VitapedCombination | United States | 80MG/VIAL; 0.02MG/VIAL; 0.001MG/VIAL; 400 IU/10ML,N/A; 0.14MG/VIAL; 17MG/VIAL; 5MG/VIAL; 0.2MG/10ML,N/A; 1MG/VIAL; 1.4MG/VIAL; 1.2MG/VIAL; 2,300 UNITS BASE/10ML,N/A; 7 IU/10ML,N/A | injectable | Not marketed | Hospira |
| D-Forte | Canada | 50000 UNIT | Capsule | Not marketed | Euro-Pharm International Canada INC |
| Sandoz D-Forte | Canada | 50000 UNIT | Capsule | Not marketed | Sandoz Canada Incorporated |